Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cerebral Cortex (New York, N.Y. : 1991)|April 25, 2013
Impaired GABAergic inhibition in the prefrontal cortex of early postnatal phencyclidine (PCP)-treated ratsCelia Kjaerby, Brian V Broberg, Uffe Kristiansen, et al.
Journal of Neurochemistry|October 23, 2012
Differential expression of parvalbumin in neonatal phencyclidine-treated rats and socially isolated ratsSanne S Kaalund, Jesper Riise, Brian V Broberg, et al.
Frontiers in Psychiatry|February 13, 2019
Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral DensityRobert Eriksson, Brian V Broberg, Pelle L Ishøy, et al.
Behavioural Brain Research|May 7, 2013
A schizophrenia rat model induced by early postnatal phencyclidine treatment and characterized by Magnetic Resonance ImagingBrian V Broberg, Kristoffer H Madsen, Niels Plath, et al.
The International Journal of Neuropsychopharmacology|May 9, 2022
Lower Vitamin C Levels Are Associated With Less Improvement in Negative Symptoms in Initially Antipsychotic-Naïve Patients With First-Episode PsychosisAnders N Myken, Bjørn H Ebdrup, Mikkel E Sørensen, et al.
Psychoneuroendocrinology|June 22, 2015
Postprandial prolactin suppression appears absent in antipsychotic-treated male patientsKlara Coello, Brian V Broberg, Nikolaj Bak, et al.
Diabetes, Obesity & Metabolism|October 8, 2016
Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trialPelle L Ishøy, Filip K Knop, Brian V Broberg, et al.
BMJ Open|January 10, 2014
Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist--protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocolPelle L Ishøy, Filip K Knop, Brian V Broberg, et al.
Psychological Medicine|September 17, 2019
Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosisKirsten B Bojesen, Bjørn H Ebdrup, Kasper Jessen, et al.
Psychoneuroendocrinology|April 11, 2018
Multiple measures of HPA axis function in ultra high risk and first-episode schizophrenia patientsDorte Nordholm, Egill Rostrup, Valeria Mondelli, et al.
Pageof 2